Apr 24 Watch 6:14 How federal case against drug distributor could change opioid fight Amid the ongoing opioid epidemic, drug manufacturers, doctors and pharmacists have all come under fire. But it's a drug distributor, a company called RDC, at the center of a new federal criminal case that equates its business operations with illegal… Continue watching
Feb 26 WATCH: Drug companies ‘bear none of the consequences’ of skyrocketing prices, Sen. Wyden says By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press The hearing marks the first time lawmakers have called top industry executives to account for rising prices that are squeezing Americans. Continue reading
Jan 14 House Democrats announce they are investigating drug pricing By Ricardo Alonso-Zaldivar, Associated Press House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political spectrum. Continue reading
Aug 11 Watch 11:08 Do prescription drug middlemen help keep prices high? By Megan Thompson, Mori Rothman Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for a portion of those high costs through their role as… Continue watching
Jun 30 Justice Department announces crackdown on fraudulent opioid prescriptions By Lev Facher, STAT Federal agencies on Thursday announced charges in what Attorney General Jeff Sessions called “the largest health care fraud takedown in American history,” an investigation into over $2 billion in alleged fraud by doctors, pharmacists, and nurses. Continue reading
May 23 Column: Not sure what to make of Trump’s drug prices plan? Here’s where to start By Philip Moeller Rushing to judgment is misguided. There are no quick fixes here, and while the Trump proposals are viewed as fatally flawed by many experts, they also include some worthy ideas. Continue reading
Jun 07 Nevada bill would require insulin makers to post profits By Emily Kopp, Kaiser Health News The cost of insulin medications has steadily risen over the past decade by nearly 300 percent. Continue reading
Dec 06 Who wins and loses with the 21st Century Cures Act? By Sheila Kaplan, STAT More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies. Continue reading
Jun 02 Column: Our zeal for antibiotics in agriculture could become an economic nightmare By Vikram Mansharamani The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll. Continue reading
Feb 10 Lower drug prices: Does any candidate have an Rx? By Philip Moeller The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office. Continue reading